Catherine H. Orteu

1.8k total citations
32 papers, 943 citations indexed

About

Catherine H. Orteu is a scholar working on Pathology and Forensic Medicine, Dermatology and Rheumatology. According to data from OpenAlex, Catherine H. Orteu has authored 32 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 12 papers in Dermatology and 10 papers in Rheumatology. Recurrent topics in Catherine H. Orteu's work include Autoimmune Bullous Skin Diseases (9 papers), Lysosomal Storage Disorders Research (6 papers) and Systemic Sclerosis and Related Diseases (6 papers). Catherine H. Orteu is often cited by papers focused on Autoimmune Bullous Skin Diseases (9 papers), Lysosomal Storage Disorders Research (6 papers) and Systemic Sclerosis and Related Diseases (6 papers). Catherine H. Orteu collaborates with scholars based in United Kingdom, Italy and Germany. Catherine H. Orteu's co-authors include Arne N. Akbar, Mike Salmon, Jan Dutz, Amanda Saracino, Christopher D. Buckley, Nicola Borthwick, Nicole Amft, Darrell Pilling, Dagmar Scheel‐Toellner and John Girdlestone and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Catherine H. Orteu

27 papers receiving 906 citations

Peers

Catherine H. Orteu
Elizabeth Whalen United States
David H. Gardner United Kingdom
Felice Rivellese United Kingdom
Adriana M. C. Mus Netherlands
Elizabeth Whalen United States
Catherine H. Orteu
Citations per year, relative to Catherine H. Orteu Catherine H. Orteu (= 1×) peers Elizabeth Whalen

Countries citing papers authored by Catherine H. Orteu

Since Specialization
Citations

This map shows the geographic impact of Catherine H. Orteu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine H. Orteu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine H. Orteu more than expected).

Fields of papers citing papers by Catherine H. Orteu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine H. Orteu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine H. Orteu. The network helps show where Catherine H. Orteu may publish in the future.

Co-authorship network of co-authors of Catherine H. Orteu

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine H. Orteu. A scholar is included among the top collaborators of Catherine H. Orteu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine H. Orteu. Catherine H. Orteu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Campos, Luiza C., George Meligonis, David M. Lowe, et al.. (2025). Skin Manifestations in Adults With Chronic Granulomatous Disease in the United Kingdom. The Journal of Allergy and Clinical Immunology In Practice. 13(8). 2151–2161.e7.
2.
Carmichael, Andrew, et al.. (2024). Morphoea presenting histopathologically as mycosis fungoides: an illustrative series of four cases. Histopathology. 85(2). 353–358.
3.
Orteu, Catherine H., et al.. (2024). O06 Abatacept efficacy in severe refractory morphoea: experience from a specialized centre. British Journal of Dermatology. 191(Supplement_1). i4–i4.
4.
Clark, Kristina E N, et al.. (2023). Skin biopsy analysis of concurrent keloidal morphoea and systemic sclerosis confirms overlapping pathogenic pathways. Clinical and Experimental Rheumatology. 41(8). 1644–1651.
5.
Foeldvari, Ivan, Kathryn S. Torok, Jordi Antón, et al.. (2023). Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022. Expert Review of Clinical Immunology. 20(4). 387–404. 2 indexed citations
6.
O’Kane, Donal, Collette McCourt, Simon Meggitt, et al.. (2021). British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021. British Journal of Dermatology. 185(6). 1112–1123. 14 indexed citations
7.
Scheel‐Toellner, Dagmar, Arne N. Akbar, Darrell Pilling, et al.. (2021). Type I interferons inhibit the resolution of chronic inflammation. PubMed. 52. 277–288.
8.
Orteu, Catherine H., Voon H Ong, & Christopher P. Denton. (2020). Scleroderma mimics – Clinical features and management. Best Practice & Research Clinical Rheumatology. 34(1). 101489–101489. 11 indexed citations
9.
Zampetti, Anna, Catherine H. Orteu, Daniela Antuzzi, et al.. (2012). Angiokeratoma: decision-making aid for the diagnosis of Fabry disease. British Journal of Dermatology. 166(4). 712–720. 29 indexed citations
10.
Hughes, Derralynn, et al.. (2012). Pseudoacromegalic facial features in Fabry disease. Clinical and Experimental Dermatology. 38(2). 137–139. 4 indexed citations
11.
Hughes, Derralynn, Patrick Deegan, Perry Elliott, et al.. (2012). Fabry International Prognostic Index: a predictive severity score for Anderson-Fabry disease. Journal of Medical Genetics. 49(3). 212–220. 19 indexed citations
12.
Orteu, Catherine H., Thomas Jansen, Olivier Lidove, et al.. (2007). Fabry disease and the skin: data from FOS, the Fabry outcome survey. British Journal of Dermatology. 157(2). 331–337. 94 indexed citations
13.
O’Brien, Bronwyn A., Xuan Geng, Catherine H. Orteu, et al.. (2006). A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. Journal of Autoimmunity. 26(2). 104–115. 91 indexed citations
14.
Orteu, Catherine H., et al.. (2005). Dementia associated with scleromyxoedema reversed by high-dose intravenous immunoglobulin. British Journal of Dermatology. 153(3). 650–652. 20 indexed citations
15.
Reed, John R., Milica Vukmanovic‐Stejic, Jean M. Fletcher, et al.. (2004). Telomere Erosion in Memory T Cells Induced by Telomerase Inhibition at the Site of Antigenic Challenge In Vivo. The Journal of Experimental Medicine. 199(10). 1433–1443. 97 indexed citations
16.
Hu, Yuxiang, et al.. (2003). Optimization of epicutaneous immunization for the induction of CTL. Vaccine. 21(21-22). 2890–2899. 53 indexed citations
17.
Orteu, Catherine H., Richard D. Sontheimer, & Jan Dutz. (2001). The pathophysiology of photosensitivity in lupus erythematosus. Photodermatology Photoimmunology & Photomedicine. 17(3). 95–113. 31 indexed citations
18.
Orton, David, Catherine H. Orteu, & M.H.A. Rustin. (2001). Cytomegalovirus-associated gastric ulcer in an immunosuppressed patient with pemphigus vulgaris. Clinical and Experimental Dermatology. 26(2). 170–172. 9 indexed citations
19.
Orteu, Catherine H. & M.H.A. RUSTIN. (1996). 20 thickened, fragile nails. The Lancet. 347(9002). 662–662. 4 indexed citations
20.
Orteu, Catherine H., J.M. McGregor, John Almeyda, & M.H.A. Rustin. (1995). Recurrence of hyperhidrosis after endoscopic transthoracic sympathectomy-case report and review of the literature. Clinical and Experimental Dermatology. 20(3). 230–233. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026